Scarica l'app Stockscreener
0.96
15.04%
-0.17
Pre-mercato:
.98
0.02
+2.08%
Precedente Chiudi:
$1.13
Aprire:
$1.1
Volume 24 ore:
3.48M
Relative Volume:
0.09
Capitalizzazione di mercato:
$44.21M
Reddito:
-
Utile/perdita netta:
$-4.23M
Rapporto P/E:
-4.5541
EPS:
-0.2108
Flusso di cassa netto:
-
1 W Prestazione:
-28.89%
1M Prestazione:
+33.31%
6M Prestazione:
+131.33%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.921
$1.12
Intervallo di 1 settimana:
$0.921
$1.34
Portata 52W:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Nome
Klotho Neurosciences Inc
Settore
Industria
Telefono
646-916-5315
Indirizzo
1115 BROADWAY, NEW YORK
Confronta KLTO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.96 | 41.24M | 0 | -4.23M | 0 | -0.2108 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Klotho Neurosciences Inc Borsa (KLTO) Ultime notizie
What’s the recovery path for long term holders of Klotho Neurosciences Inc.Strategy Playbook for Risk Controlled Trades - Newser
How does Klotho Neurosciences Inc. compare to its industry peersReal Time Planner For Fast Growth - jammulinksnews.com
Does Klotho Neurosciences Inc. stock perform well during market downturnsStock Market Ideas With Proven Results - jammulinksnews.com
What is Klotho Neurosciences Inc. Equity Warrant company’s growth strategyIdentify breakout stocks before they peak - jammulinksnews.com
Is Klotho Neurosciences Inc. Equity Warrant a growth stock or a value stockFree Stock Market Trend Analysis - jammulinksnews.com
Signal strength of Klotho Neurosciences Inc. stock in tech scannersTrading Opportunities Forecast by AI Insight - Newser
What makes Klotho Neurosciences Inc. stock price move sharplyFree Technical Stock Breakout Predictions - Newser
Exit strategy if you’re trapped in Klotho Neurosciences Inc.AI Driven Swing Trade Forecasting Insight - Newser
Developing predictive dashboards with Klotho Neurosciences Inc. Equity Warrant dataReal-Time Signal Tracking with Entry Level - Newser
Why Klotho Neurosciences Inc. Equity Warrant stock attracts strong analyst attentionEntry Opportunity Screener with Confirmation - Newser
How strong is Klotho Neurosciences Inc. Equity Warrant company’s balance sheetMaximize your returns with smart trade entries - jammulinksnews.com
Is Klotho Neurosciences Inc. a growth stock or a value stockBuild a portfolio that withstands market volatility - jammulinksnews.com
Published on: 2025-07-28 03:22:51 - jammulinksnews.com
How does Klotho Neurosciences Inc. Equity Warrant generate profit in a changing economyCapitalize on proven investment strategies - jammulinksnews.com
Is it the right time to buy Klotho Neurosciences Inc. Equity Warrant stockUnlock exclusive trading strategies for gains - jammulinksnews.com
What catalysts could drive Klotho Neurosciences Inc. Equity Warrant stock higher in 2025Significant capital appreciation - jammulinksnews.com
What makes Klotho Neurosciences Inc. Equity Warrant stock price move sharplyTrend Based Entry Alerts - metal.it
What are analysts’ price targets for Klotho Neurosciences Inc. in the next 12 monthsTurn market volatility into profit opportunities - jammulinksnews.com
How volatile is Klotho Neurosciences Inc. Equity Warrant stock compared to the marketMaximize your portfolio’s growth potential - jammulinksnews.com
Will Klotho Neurosciences Inc. stock split in the near futureLong Term Secure Gain Stocks - metal.it
Published on: 2025-07-27 22:05:50 - jammulinksnews.com
Klotho Neurosciences Inc. Equity Warrant Earnings Report Breakdown: What Investors Should KnowFree Exclusive Investment Tips - Newser
Is Klotho Neurosciences Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Wealth-Building Investment Strategies - Newser
Will Klotho Neurosciences Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Selection with 300% Return - Newser
Klotho Neurosciences regains full compliance with Nasdaq listing standards - MSN
Klotho Neurosciences: A Strategic Pivot to Longevity and Diversified Biotech Growth - AInvest
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - The Malaysian Reserve
Klotho Targets Multiple Age-Related Diseases with Breakthrough Gene Platform - Stock Titan
What analysts say about Klotho Neurosciences Inc. Equity Warrant stockHigh-return market picks - PrintWeekIndia
Klotho Neurosciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia
Is Klotho Neurosciences Inc. a good long term investmentExceptional trading results - PrintWeekIndia
How Klotho Neurosciences Inc. stock reacts to Fed policy changesOverwhelming profit margins - jammulinksnews.com
What analysts say about Klotho Neurosciences Inc. stockRemarkably fast returns - Autocar Professional
What drives Klotho Neurosciences Inc. Equity Warrant stock priceOver 200% growth - Autocar Professional
Does Klotho Neurosciences Inc. stock pay reliable dividendsTremendous return on equity - jammulinksnews.com
Klotho Neurosciences seeking to expand into adjacent technologies - TipRanks
Major Anti-Aging Breakthrough: Klotho Sciences Targets Multiple Age-Related Diseases with New Platform - Stock Titan
What drives Klotho Neurosciences Inc. stock priceMarket-crushing stock picks - Autocar Professional
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets - The Malaysian Reserve
Klotho Neurosciences Inc Azioni (KLTO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10.28%
2.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):